|Articles|September 13, 2022
WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research
Expanded services will provide faster timelines in the clinical trial process for early stage and clinical pharmacology research.
Advertisement
WCG announced the expansion of its Phase I review services. Launched in conjunction with the opening of Dr. Vince Clinical Research’s (DVCR) research complex in Overland Park, Kansas—these services are intended to improve timelines in the clinical trial process while maintaining necessary human subject protection for early stage and clinical pharmacology research.
Read more about the expansion and partnership here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMGSeptember 15th 2025
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
